These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 5442296)

  • 1. Mechanisms by which amphetamine and desipramine inhibit the metaraminol-induced release of norepinephrine from sympathetic nerve endings in rat heart.
    Leitz FH
    J Pharmacol Exp Ther; 1970 May; 173(1):152-7. PubMed ID: 5442296
    [No Abstract]   [Full Text] [Related]  

  • 2. Protection by desipramine of 6-hydroxydopamine induced damage to adrenergic nerve terminals in mouse heart.
    Bonagura V; Cassebaum L; Dangman K; Freund J; Cabbat F; Dembiec D; Heikkila R; Cohen G
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):163-71. PubMed ID: 4671960
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of drugs on the 6-hydroxydopamine induced degeneration of adrenergic nerves.
    Jonsson G; Malmfors T; Sachs C
    Res Commun Chem Pathol Pharmacol; 1972 May; 3(3):543-56. PubMed ID: 5034513
    [No Abstract]   [Full Text] [Related]  

  • 4. Action of angiotensin on adrenergic nerve endings: inhibition of norepinephrine uptake.
    Khairallah PA
    Fed Proc; 1972; 31(4):1351-7. PubMed ID: 4402613
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of tyramine, amphetamine and metaraminol on the metabolic disposition of 3 H-norepinephrine released from the adrenergic neuron.
    Leitz FH; Stefano FJ
    J Pharmacol Exp Ther; 1971 Sep; 178(3):464-73. PubMed ID: 4105925
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of bretylium on amine retention in rat heart.
    Krauss KR; Kopin IJ; Weise VK
    J Pharmacol Exp Ther; 1970 Apr; 172(2):282-8. PubMed ID: 4392531
    [No Abstract]   [Full Text] [Related]  

  • 7. Guanethidine and related agents. I. Mechanism of the selective blockade of adrenergic neurons and its antagonism by drugs.
    Mitchell JR; Oates JA
    J Pharmacol Exp Ther; 1970 Mar; 172(1):100-7. PubMed ID: 5416937
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of various local anesthetics and metanephrine on the uptake of tritiated noradrenaline uptake by the rat heart].
    Damas J; Thiriet E; Chartry-Trinon J
    C R Seances Soc Biol Fil; 1971; 165(9):2023-6. PubMed ID: 4263147
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the possibility of chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-hydroxydopamine (6-OH-DA)].
    Thoenen H; Tranzer JP
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):212-3. PubMed ID: 4239240
    [No Abstract]   [Full Text] [Related]  

  • 10. Degenerative and nondegenerative effects of 6-hydroxydopamine on adrenergic nerves.
    Jonsson G; Sachs C
    J Pharmacol Exp Ther; 1972 Mar; 180(3):625-35. PubMed ID: 4335111
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the physiologic disposition and activity of phenylpropanolamines in the mouse.
    Levitt M; Cumiskey WR; Shargel L
    Drug Metab Dispos; 1974; 2(2):187-93. PubMed ID: 4150999
    [No Abstract]   [Full Text] [Related]  

  • 12. Developmental shift from local to central control of norepinephrine release in the cardiac-sympathetic axis: effects of cocaine and related drugs.
    Nye HE; Seidler FJ; Slotkin TA
    J Pharmacol Exp Ther; 1991 Dec; 259(3):976-81. PubMed ID: 1762090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of protriptyline on the disappearance and nerve impulse induced release of labelled metaraminol in the rat.
    Almgren O
    Acta Physiol Scand; 1971 Aug; 82(4):539-44. PubMed ID: 4329133
    [No Abstract]   [Full Text] [Related]  

  • 14. Interaction between desipramine, tyramine, and amphetamine at adrenergic neurones.
    Brodie BB; Costa E; Groppetti A; Matsumoto C
    Br J Pharmacol; 1968 Nov; 34(3):648-58. PubMed ID: 5726793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of responses to adrenergic nerve stimulation in isolated rat atria during chronic tricyclic antidepressant administration.
    Crews FT; Smith CB
    J Pharmacol Exp Ther; 1980 Oct; 215(1):143-9. PubMed ID: 6256516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake, retention and metabolism of H 3 -tyramine in rat atria.
    Steinberg MI; Smith CB
    J Pharmacol Exp Ther; 1971 Jan; 176(1):139-48. PubMed ID: 4936457
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of ouabain-induced noradrenaline and acetylcholine release from in situ cardiac autonomic nerve endings.
    Yamazaki T; Akiyama T; Kitagawa H; Komaki F; Mori H; Kawada T; Sunagawa K; Sugimachi M
    Acta Physiol (Oxf); 2007 Dec; 191(4):275-84. PubMed ID: 17995575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of cardiac neurotrophic factors and sympathetic nerve ending abnormalities within the failing heart.
    Kreusser MM; Buss SJ; Krebs J; Kinscherf R; Metz J; Katus HA; Haass M; Backs J
    J Mol Cell Cardiol; 2008 Feb; 44(2):380-7. PubMed ID: 18037433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desipramine-induced release of norepinephrine from heart.
    Leitz FH; Stefano FJ
    Biochem Pharmacol; 1970 May; 19(5):1797-801. PubMed ID: 5513960
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of ouabain and desipramine on the uptake and storage of norepinephrine and metaraminol.
    Leitz FH; Stefano FJ
    Eur J Pharmacol; 1970; 11(3):278-85. PubMed ID: 5477305
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.